Zealand Pharma — Juni 2024
-
Morning sharks:)
-
@YPE stort tillykke!
-
OVERBLIK: Disse selskaber er shortet på det danske aktiemarked https://proinvestor.com/investornyt/1169366/overblik-disse-selskaber-er-shortet-pa-det-danske-aktiemarked
-
(ps lidt pudsigt - solgte nogle til udbetaling på sommerhus - fruen nægede da jeg bad om at det skulle hedde Zealand Pharma og stå på muren i guld:) Øv
-
godt og velbekomme- så kan vi smile når vi kører forbi huse og sejler forbi både - og nikke vel vidende..
-
Ps Zealand smukt navn til båd
-
jeps - og god vind til båden i dag:)
-
ups -
-
****ZEALAND PHARMA: PARTNER VIL PRÆSENTERE POSITIVE DATA FRA FASE 2 MED SURVODUTIDE I MASH
-
****ZEALAND PHARMA: DATA HAR KORTVARIGT VÆRET OFFENTLIGGJORT PÅ AMERIKANSK KONGRES HJEMMESIDE
-
"The new results in the abstract include a key secondary endpoint of improvement in fibrosis (≥1 stage decrease) without worsening of MASH, confirming highly statistically significant and clinically relevant reductions in liver scarring (fibrosis) stages F1, F2 and F3 (mild to moderate or advanced scarring) with survodutide. In this trial, survodutide demonstrated safety data consistent with GLP-1 based molecules, with no new safety data concerns".
-
"
Prior to Zealand Pharma being made aware that information was made available, Zealand Pharma has received no information about the results. Zealand Pharma will provide further information as and when relevant". -
tak Helge
-
Ilm ST.
-
:allways:)
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind